Back to Journals » Drug Design, Development and Therapy » Volume 18

Neurophysiological Characteristics in Type II and Type III 5q Spinal Muscular Atrophy Patients: Impact of Nusinersen Treatment

Total article views   HTML views PDF downloads Totals
1,605 Dovepress* 1,549+ 34 1,583
PubMed Central* 56 54 110
Totals 1,605 88 1,693
*Since 28 March 2024

View citations on PubMed Central and Google Scholar